Skip to main content
Top
Published in: European Journal of Epidemiology 12/2014

01-12-2014 | MORTALITY

Repeated measures of body mass index and C-reactive protein in relation to all-cause mortality and cardiovascular disease: results from the consortium on health and ageing network of cohorts in Europe and the United States (CHANCES)

Authors: Mark G. O’Doherty, Torben Jørgensen, Anders Borglykke, Hermann Brenner, Ben Schöttker, Tom Wilsgaard, Galatios Siganos, Maryam Kavousi, Maria Hughes, Aysel Müezzinler, Bernd Holleczek, Oscar H. Franco, Albert Hofman, Paolo Boffetta, Antonia Trichopoulou, Frank Kee

Published in: European Journal of Epidemiology | Issue 12/2014

Login to get access

Abstract

Obesity has been linked with elevated levels of C-reactive protein (CRP), and both have been associated with increased risk of mortality and cardiovascular disease (CVD). Previous studies have used a single ‘baseline’ measurement and such analyses cannot account for possible changes in these which may lead to a biased estimation of risk. Using four cohorts from CHANCES which had repeated measures in participants 50 years and older, multivariate time-dependent Cox proportional hazards was used to estimate hazard ratios (HR) and 95 % confidence intervals (CI) to examine the relationship between body mass index (BMI) and CRP with all-cause mortality and CVD. Being overweight (≥25–<30 kg/m2) or moderately obese (≥30–<35) tended to be associated with a lower risk of mortality compared to normal (≥18.5–<25): ESTHER, HR (95 % CI) 0.69 (0.58–0.82) and 0.78 (0.63–0.97); Rotterdam, 0.86 (0.79–0.94) and 0.80 (0.72–0.89). A similar relationship was found, but only for overweight in Glostrup, HR (95 % CI) 0.88 (0.76–1.02); and moderately obese in Tromsø, HR (95 % CI) 0.79 (0.62–1.01). Associations were not evident between repeated measures of BMI and CVD. Conversely, increasing CRP concentrations, measured on more than one occasion, were associated with an increasing risk of mortality and CVD. Being overweight or moderately obese is associated with a lower risk of mortality, while CRP, independent of BMI, is positively associated with mortality and CVD risk. If inflammation links CRP and BMI, they may participate in distinct/independent pathways. Accounting for independent changes in risk factors over time may be crucial for unveiling their effects on mortality and disease morbidity.
Appendix
Available only for authorised users
Literature
2.
go back to reference Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309:71–82.PubMedCrossRef Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309:71–82.PubMedCrossRef
3.
go back to reference Borrell LN, Samuel L. Body mass index categories and mortality risk in US Adults: the effect of overweight and obesity on advancing death. Am J Public Health. 2014;104:512–9.PubMedCrossRef Borrell LN, Samuel L. Body mass index categories and mortality risk in US Adults: the effect of overweight and obesity on advancing death. Am J Public Health. 2014;104:512–9.PubMedCrossRef
4.
go back to reference Wang Z. Age and the impact of obesity on mortality. Am J Public Health. 2014;104:e3. Wang Z. Age and the impact of obesity on mortality. Am J Public Health. 2014;104:e3.
5.
go back to reference Masters RK, Reither EN, Powers DA, Yang YC, Burger AE, Link BG. The impact of obesity on US mortality levels: the importance of age and cohort factors in population estimates. Am J Public Health. 2013;103:1895–901.PubMedCentralPubMedCrossRef Masters RK, Reither EN, Powers DA, Yang YC, Burger AE, Link BG. The impact of obesity on US mortality levels: the importance of age and cohort factors in population estimates. Am J Public Health. 2013;103:1895–901.PubMedCentralPubMedCrossRef
6.
go back to reference Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083–96.PubMedCrossRef Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083–96.PubMedCrossRef
8.
go back to reference Flint AJ, Hu FB, Glynn RJ, Caspard H, Manson JE, Willett WC, et al. Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring). 2010;18:377–83.PubMedCentralPubMedCrossRef Flint AJ, Hu FB, Glynn RJ, Caspard H, Manson JE, Willett WC, et al. Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring). 2010;18:377–83.PubMedCentralPubMedCrossRef
9.
go back to reference Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, et al. Body-mass index and mortality among 1.46 million white adults. N. Engl. J. Med. 2010;363: 2211–9. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, et al. Body-mass index and mortality among 1.46 million white adults. N. Engl. J. Med. 2010;363: 2211–9.
10.
go back to reference Després J-P. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126:1301–13.PubMedCrossRef Després J-P. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126:1301–13.PubMedCrossRef
12.
go back to reference Rodríguez-Hernández H, Simental-Mendía LE, Rodríguez-Ramírez G, Reyes-Romero MA. Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. Int J Endocrinol. 2013;2013:678159.PubMedCentralPubMedCrossRef Rodríguez-Hernández H, Simental-Mendía LE, Rodríguez-Ramírez G, Reyes-Romero MA. Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. Int J Endocrinol. 2013;2013:678159.PubMedCentralPubMedCrossRef
13.
go back to reference Currie CJ, Poole CD, Conway P. Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality. Heart. 2008;94:457–62.PubMedCrossRef Currie CJ, Poole CD, Conway P. Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality. Heart. 2008;94:457–62.PubMedCrossRef
14.
go back to reference Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375:132–40.PubMedCrossRef Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375:132–40.PubMedCrossRef
15.
go back to reference Giovannini S, Onder G, Liperoti R, Russo A, Carter C, Capoluongo E, et al. Interleukin-6, C-reactive protein, and tumor necrosis factor-alpha as predictors of mortality in frail, community-living elderly individuals. J Am Geriatr Soc. 2011;59:1679–85.PubMedCrossRef Giovannini S, Onder G, Liperoti R, Russo A, Carter C, Capoluongo E, et al. Interleukin-6, C-reactive protein, and tumor necrosis factor-alpha as predictors of mortality in frail, community-living elderly individuals. J Am Geriatr Soc. 2011;59:1679–85.PubMedCrossRef
16.
go back to reference Pepys MB, Rowe IF, Baltz ML. C-reactive protein: binding to lipids and lipoproteins. Int Rev Exp Pathol. 1985;27:83–111.PubMed Pepys MB, Rowe IF, Baltz ML. C-reactive protein: binding to lipids and lipoproteins. Int Rev Exp Pathol. 1985;27:83–111.PubMed
17.
go back to reference Zhang YX, Cliff WJ, Schoefl GI, Higgins G. Coronary C-reactive protein distribution: its relation to development of atherosclerosis. Atherosclerosis. 1999;145:375–9.PubMedCrossRef Zhang YX, Cliff WJ, Schoefl GI, Higgins G. Coronary C-reactive protein distribution: its relation to development of atherosclerosis. Atherosclerosis. 1999;145:375–9.PubMedCrossRef
18.
go back to reference Bisoendial RJ, Boekholdt SM, Vergeer M, Stroes ESG, Kastelein JJP. C-reactive protein is a mediator of cardiovascular disease. Eur Heart J. 2010;31:2087–91.PubMedCrossRef Bisoendial RJ, Boekholdt SM, Vergeer M, Stroes ESG, Kastelein JJP. C-reactive protein is a mediator of cardiovascular disease. Eur Heart J. 2010;31:2087–91.PubMedCrossRef
19.
go back to reference Anand SS, Yusuf S. C-reactive protein is a bystander of cardiovascular disease. Eur Heart J. 2010;31:2092–6.PubMedCrossRef Anand SS, Yusuf S. C-reactive protein is a bystander of cardiovascular disease. Eur Heart J. 2010;31:2092–6.PubMedCrossRef
20.
go back to reference Danesh J, Pepys MB. C-reactive protein and coronary disease: is there a causal link? Circulation. 2009;120:2036–9.PubMedCrossRef Danesh J, Pepys MB. C-reactive protein and coronary disease: is there a causal link? Circulation. 2009;120:2036–9.PubMedCrossRef
21.
go back to reference Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012;367:1310–20.PubMedCrossRef Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012;367:1310–20.PubMedCrossRef
22.
go back to reference Zacho J, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein and all-cause mortality—the Copenhagen City Heart Study. Eur Heart J. 2010;31:1624–32.PubMedCrossRef Zacho J, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein and all-cause mortality—the Copenhagen City Heart Study. Eur Heart J. 2010;31:1624–32.PubMedCrossRef
23.
go back to reference Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350:1387–97.PubMedCrossRef Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350:1387–97.PubMedCrossRef
24.
go back to reference Casas JP, Shah T, Hingorani AD, Danesh J, Pepys MB. C-reactive protein and coronary heart disease: a critical review. J Intern Med. 2008;264:295–314.PubMedCrossRef Casas JP, Shah T, Hingorani AD, Danesh J, Pepys MB. C-reactive protein and coronary heart disease: a critical review. J Intern Med. 2008;264:295–314.PubMedCrossRef
26.
go back to reference Somes GW, Kritchevsky SB, Shorr RI, Pahor M, Applegate WB. Body mass index, weight change, and death in older adults: the systolic hypertension in the elderly program. Am J Epidemiol. 2002;156:132–8.PubMedCrossRef Somes GW, Kritchevsky SB, Shorr RI, Pahor M, Applegate WB. Body mass index, weight change, and death in older adults: the systolic hypertension in the elderly program. Am J Epidemiol. 2002;156:132–8.PubMedCrossRef
27.
go back to reference Reas DL, Nygård JF, Svensson E, Sørensen T, Sandanger I. Changes in body mass index by age, gender, and socio-economic status among a cohort of Norwegian men and women (1990–2001). BMC Public Health. 2007;7:269.PubMedCentralPubMedCrossRef Reas DL, Nygård JF, Svensson E, Sørensen T, Sandanger I. Changes in body mass index by age, gender, and socio-economic status among a cohort of Norwegian men and women (1990–2001). BMC Public Health. 2007;7:269.PubMedCentralPubMedCrossRef
28.
go back to reference Claessen H, Brenner H, Drath C, Arndt V. Repeated measures of body mass index and risk of health related outcomes. Eur J Epidemiol. 2012;27:215–24.PubMedCrossRef Claessen H, Brenner H, Drath C, Arndt V. Repeated measures of body mass index and risk of health related outcomes. Eur J Epidemiol. 2012;27:215–24.PubMedCrossRef
29.
go back to reference Osler M, Linneberg A, Glümer C, Jørgensen T. The cohorts at the Research Centre for Prevention and Health, formerly “The Glostrup Population Studies”. Int J Epidemiol. 2011;40:602–10.PubMedCrossRef Osler M, Linneberg A, Glümer C, Jørgensen T. The cohorts at the Research Centre for Prevention and Health, formerly “The Glostrup Population Studies”. Int J Epidemiol. 2011;40:602–10.PubMedCrossRef
30.
go back to reference Schöttker B, Müller H, Rothenbacher D, Brenner H. Fasting plasma glucose and HbA1c in cardiovascular risk prediction: a sex-specific comparison in individuals without diabetes mellitus. Diabetologia. 2013;56:92–100.PubMedCrossRef Schöttker B, Müller H, Rothenbacher D, Brenner H. Fasting plasma glucose and HbA1c in cardiovascular risk prediction: a sex-specific comparison in individuals without diabetes mellitus. Diabetologia. 2013;56:92–100.PubMedCrossRef
32.
go back to reference Hofman A, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, Ikram MA, et al. The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol. 2013;28:889–926.PubMedCrossRef Hofman A, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, Ikram MA, et al. The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol. 2013;28:889–926.PubMedCrossRef
33.
go back to reference Lisko I, Tiainen K, Stenholm S, Luukkaala T, Hervonen A, Jylhä M. Body mass index, waist circumference, and waist-to-hip ratio as predictors of mortality in nonagenarians: the Vitality 90+ Study. J Gerontol A Biol Sci Med Sci. 2011;66:1244–50.PubMedCrossRef Lisko I, Tiainen K, Stenholm S, Luukkaala T, Hervonen A, Jylhä M. Body mass index, waist circumference, and waist-to-hip ratio as predictors of mortality in nonagenarians: the Vitality 90+ Study. J Gerontol A Biol Sci Med Sci. 2011;66:1244–50.PubMedCrossRef
34.
go back to reference Petursson H, Sigurdsson JA, Bengtsson C, Nilsen TIL, Getz L. Body configuration as a predictor of mortality: comparison of five anthropometric measures in a 12 year follow-up of the Norwegian HUNT 2 study. PLoS One. 2011;6:e26621.PubMedCentralPubMedCrossRef Petursson H, Sigurdsson JA, Bengtsson C, Nilsen TIL, Getz L. Body configuration as a predictor of mortality: comparison of five anthropometric measures in a 12 year follow-up of the Norwegian HUNT 2 study. PLoS One. 2011;6:e26621.PubMedCentralPubMedCrossRef
35.
go back to reference Cohen SS, Signorello LB, Cope EL, McLaughlin JK, Hargreaves MK, Zheng W, et al. Obesity and all-cause mortality among black adults and white adults. Am J Epidemiol. 2012;176:431–42.PubMedCentralPubMedCrossRef Cohen SS, Signorello LB, Cope EL, McLaughlin JK, Hargreaves MK, Zheng W, et al. Obesity and all-cause mortality among black adults and white adults. Am J Epidemiol. 2012;176:431–42.PubMedCentralPubMedCrossRef
36.
go back to reference Flicker L, McCaul KA, Hankey GJ, Jamrozik K, Brown WJ, Byles JE, et al. Body mass index and survival in men and women aged 70–75. J Am Geriatr Soc. 2010;58:234–41.PubMedCrossRef Flicker L, McCaul KA, Hankey GJ, Jamrozik K, Brown WJ, Byles JE, et al. Body mass index and survival in men and women aged 70–75. J Am Geriatr Soc. 2010;58:234–41.PubMedCrossRef
37.
go back to reference Mikkelsen KL, Heitmann BL, Keiding N, Sørensen TI. Independent effects of stable and changing body weight on total mortality. Epidemiology. 1999;10:671–8.PubMedCrossRef Mikkelsen KL, Heitmann BL, Keiding N, Sørensen TI. Independent effects of stable and changing body weight on total mortality. Epidemiology. 1999;10:671–8.PubMedCrossRef
38.
go back to reference He J, McGee D, Niu X, Choi W. Examining the dynamic association of BMI and mortality in the Framingham Heart Study. Int J Environ Res Public Health. 2009;6:3115–26.PubMedCentralPubMedCrossRef He J, McGee D, Niu X, Choi W. Examining the dynamic association of BMI and mortality in the Framingham Heart Study. Int J Environ Res Public Health. 2009;6:3115–26.PubMedCentralPubMedCrossRef
39.
go back to reference Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368:666–78.PubMedCrossRef Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368:666–78.PubMedCrossRef
40.
go back to reference Oreopoulos A, McAlister FA, Kalantar-Zadeh K, Padwal R, Ezekowitz JA, Sharma AM, et al. The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH. Eur Heart J. 2009;30:2584–92.PubMedCentralPubMedCrossRef Oreopoulos A, McAlister FA, Kalantar-Zadeh K, Padwal R, Ezekowitz JA, Sharma AM, et al. The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH. Eur Heart J. 2009;30:2584–92.PubMedCentralPubMedCrossRef
41.
go back to reference Hastie CE, Padmanabhan S, Slack R, Pell ACH, Oldroyd KG, Flapan AD, et al. Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention. Eur Heart J. 2010;31:222–6.PubMedCrossRef Hastie CE, Padmanabhan S, Slack R, Pell ACH, Oldroyd KG, Flapan AD, et al. Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention. Eur Heart J. 2010;31:222–6.PubMedCrossRef
42.
go back to reference Auyeung TW, Lee JSW, Leung J, Kwok T, Leung PC, Woo J. Survival in older men may benefit from being slightly overweight and centrally obese–a 5-year follow-up study in 4,000 older adults using DXA. J Gerontol A Biol Sci Med Sci. 2010;65:99–104.PubMedCrossRef Auyeung TW, Lee JSW, Leung J, Kwok T, Leung PC, Woo J. Survival in older men may benefit from being slightly overweight and centrally obese–a 5-year follow-up study in 4,000 older adults using DXA. J Gerontol A Biol Sci Med Sci. 2010;65:99–104.PubMedCrossRef
43.
go back to reference De Hollander EL, Bemelmans WJ, Boshuizen HC, Friedrich N, Wallaschofski H, Guallar-Castillón P, et al. The association between waist circumference and risk of mortality considering body mass index in 65- to 74-year-olds: a meta-analysis of 29 cohorts involving more than 58 000 elderly persons. Int J Epidemiol. 2012;41:805–17.PubMedCrossRef De Hollander EL, Bemelmans WJ, Boshuizen HC, Friedrich N, Wallaschofski H, Guallar-Castillón P, et al. The association between waist circumference and risk of mortality considering body mass index in 65- to 74-year-olds: a meta-analysis of 29 cohorts involving more than 58 000 elderly persons. Int J Epidemiol. 2012;41:805–17.PubMedCrossRef
44.
go back to reference Nakajima K, Yamaoka H, Morita K, Ebata M, Eguchi S, Muneyuki T, et al. Elderly people with low body weight may have subtle low-grade inflammation. Obesity (Silver Spring). 2009;17:803–8.PubMedCrossRef Nakajima K, Yamaoka H, Morita K, Ebata M, Eguchi S, Muneyuki T, et al. Elderly people with low body weight may have subtle low-grade inflammation. Obesity (Silver Spring). 2009;17:803–8.PubMedCrossRef
45.
go back to reference Hubbard RE, Lang IA, Llewellyn DJ, Rockwood K. Frailty, body mass index, and abdominal obesity in older people. J Gerontol A Biol Sci Med Sci. 2010;65:377–81.PubMedCrossRef Hubbard RE, Lang IA, Llewellyn DJ, Rockwood K. Frailty, body mass index, and abdominal obesity in older people. J Gerontol A Biol Sci Med Sci. 2010;65:377–81.PubMedCrossRef
47.
go back to reference Hajer GR, van Haeften TW, Visseren FLJ. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008;29:2959–71.PubMedCrossRef Hajer GR, van Haeften TW, Visseren FLJ. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008;29:2959–71.PubMedCrossRef
48.
go back to reference Blüher M. Are there still healthy obese patients? Curr Opin Endocrinol Diabetes Obes. 2012;19:341–6.PubMedCrossRef Blüher M. Are there still healthy obese patients? Curr Opin Endocrinol Diabetes Obes. 2012;19:341–6.PubMedCrossRef
49.
go back to reference Aung K, Lorenzo C, Hinojosa MA, Haffner SM. Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. J Clin Endocrinol Metab. 2014;99:462–8.PubMedCrossRef Aung K, Lorenzo C, Hinojosa MA, Haffner SM. Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. J Clin Endocrinol Metab. 2014;99:462–8.PubMedCrossRef
50.
go back to reference Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann Intern Med. 2013;159:758–69.PubMedCrossRef Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann Intern Med. 2013;159:758–69.PubMedCrossRef
51.
go back to reference Hill JO, Wyatt HR. The myth of healthy obesity. Ann Intern Med. American College of Physicians; 2013;159: 789–90. Hill JO, Wyatt HR. The myth of healthy obesity. Ann Intern Med. American College of Physicians; 2013;159: 789–90.
52.
go back to reference Beleigoli AM, Boersma E, de Diniz M, FH Vidigal PG, Lima-Costa MF, Ribeiro AL. C-reactive protein and B-type natriuretic Peptide yield either a non-significant or a modest incremental value to traditional risk factors in predicting long-term overall mortality in older adults. PLoS One. 2013;8:e75809.PubMedCentralPubMedCrossRef Beleigoli AM, Boersma E, de Diniz M, FH Vidigal PG, Lima-Costa MF, Ribeiro AL. C-reactive protein and B-type natriuretic Peptide yield either a non-significant or a modest incremental value to traditional risk factors in predicting long-term overall mortality in older adults. PLoS One. 2013;8:e75809.PubMedCentralPubMedCrossRef
53.
go back to reference Yousuf O, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, Nasir K, et al. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol. 2013;62:397–408.PubMedCrossRef Yousuf O, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, Nasir K, et al. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol. 2013;62:397–408.PubMedCrossRef
54.
go back to reference Doran B, Zhu W, Muennig P. Gender differences in cardiovascular mortality by C-reactive protein level in the United States: evidence from the National Health and Nutrition Examination Survey III. Am Heart J. 2013;166:45–51.PubMedCrossRef Doran B, Zhu W, Muennig P. Gender differences in cardiovascular mortality by C-reactive protein level in the United States: evidence from the National Health and Nutrition Examination Survey III. Am Heart J. 2013;166:45–51.PubMedCrossRef
55.
go back to reference Gupta NK, de Lemos JA, Ayers CR, Abdullah SM, McGuire DK, Khera A. The relationship between C-reactive protein and atherosclerosis differs on the basis of body mass index: the Dallas Heart Study. J Am Coll Cardiol. 2012;60:1148–55.PubMedCrossRef Gupta NK, de Lemos JA, Ayers CR, Abdullah SM, McGuire DK, Khera A. The relationship between C-reactive protein and atherosclerosis differs on the basis of body mass index: the Dallas Heart Study. J Am Coll Cardiol. 2012;60:1148–55.PubMedCrossRef
56.
go back to reference Chapman MJ, Giral P, Barter PJ. The conundrum of C-reactive protein as a risk marker for cardiovascular risk assessment: insight from EPIC-Norfolk and JUPITER. Eur Heart J. 2013;34:1318–20.PubMedCrossRef Chapman MJ, Giral P, Barter PJ. The conundrum of C-reactive protein as a risk marker for cardiovascular risk assessment: insight from EPIC-Norfolk and JUPITER. Eur Heart J. 2013;34:1318–20.PubMedCrossRef
57.
go back to reference Whelton SP, Roy P, Astor BC, Zhang L, Hoogeveen RC, Ballantyne CM, et al. Elevated high-sensitivity C-reactive protein as a risk marker of the attenuated relationship between serum cholesterol and cardiovascular events at older age. The ARIC Study. Am J Epidemiol. 2013;178:1076–84.PubMedCentralPubMedCrossRef Whelton SP, Roy P, Astor BC, Zhang L, Hoogeveen RC, Ballantyne CM, et al. Elevated high-sensitivity C-reactive protein as a risk marker of the attenuated relationship between serum cholesterol and cardiovascular events at older age. The ARIC Study. Am J Epidemiol. 2013;178:1076–84.PubMedCentralPubMedCrossRef
58.
go back to reference Ridker PM, Wilson PWF, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation. 2004;109:2818–25.PubMedCrossRef Ridker PM, Wilson PWF, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation. 2004;109:2818–25.PubMedCrossRef
59.
go back to reference Pasternak RC, Abrams J, Greenland P, Smaha LA, Wilson PWF, Houston-Miller N. 34th Bethesda Conference: task force #1–Identification of coronary heart disease risk: is there a detection gap? J Am Coll Cardiol. 2003;41:1863–74.PubMedCrossRef Pasternak RC, Abrams J, Greenland P, Smaha LA, Wilson PWF, Houston-Miller N. 34th Bethesda Conference: task force #1–Identification of coronary heart disease risk: is there a detection gap? J Am Coll Cardiol. 2003;41:1863–74.PubMedCrossRef
60.
go back to reference White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30:377–99.PubMedCrossRef White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30:377–99.PubMedCrossRef
63.
go back to reference Zamboni M, Mazzali G, Zoico E, Harris TB, Meigs JB, Di Francesco V, et al. Health consequences of obesity in the elderly: a review of four unresolved questions. Int J Obes (Lond). 2005;29:1011–29.CrossRef Zamboni M, Mazzali G, Zoico E, Harris TB, Meigs JB, Di Francesco V, et al. Health consequences of obesity in the elderly: a review of four unresolved questions. Int J Obes (Lond). 2005;29:1011–29.CrossRef
Metadata
Title
Repeated measures of body mass index and C-reactive protein in relation to all-cause mortality and cardiovascular disease: results from the consortium on health and ageing network of cohorts in Europe and the United States (CHANCES)
Authors
Mark G. O’Doherty
Torben Jørgensen
Anders Borglykke
Hermann Brenner
Ben Schöttker
Tom Wilsgaard
Galatios Siganos
Maryam Kavousi
Maria Hughes
Aysel Müezzinler
Bernd Holleczek
Oscar H. Franco
Albert Hofman
Paolo Boffetta
Antonia Trichopoulou
Frank Kee
Publication date
01-12-2014
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 12/2014
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-014-9954-8

Other articles of this Issue 12/2014

European Journal of Epidemiology 12/2014 Go to the issue